News Release – 2009 | News Release | Hisamitsu Pharmaceutical co.,inc.

2009.12.11: Notice concerning acquisition result and acquisition end of company?fs own shares. (Acquisition of company?fs own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)

2009.12.03: Investment in Kind to our Subsidiary in the US

2009.11.12: Notice concerning the decision of matters relating to acquisition of company’s own shares. (Acquisition of company’s own shares under the regulations of the articles of association in accordance to paragraph 2, article 165 of the corporation law)

2009.11.09: Additional Indication (For relief of local pain associated with rheumatoid arthritis) Approved for “MOHRUS Tape,” a topical analgesic and anti-inflammatory product (Development Code: KPT-220)

2009.10.19: Hisamitsu Announces FDA Approval of its Fentanyl Transdermal System for Management of Chronic Pain (Development code: HFG-512)

2009.09.30: FY02/2010 Q2 Results Earnings Release Presentation

2009.08.28: Completion of the tender offer for acquisition of shares of Noven Pharmaceuticals, Inc. by our subsidiary

2009.08.25: Results of a Phase II clinical study of HTU-520 (terbinafine hydrochloride, patch), atherapeutic agent for tinea unguium

2009.08.21: Results of tender offer for acquisition of Noven Pharmaceuticals, Inc. by our subsidiary

2009.08.06: Phase II study results of HOB-294 (transdermal oxybutynin hydrochloride) for treatment of overactive bladder

2009.07.27: The 4th Medium Term Management Plan

2009.07.27: 4th Medium-term Management Objectives

2009.07.14: Acquisition of Noven Pharmaceuticals,Inc.

2009.07.14: Hisamitsu to Acquire US-based Noven Pharmaceuticals Inc.

2009.06.30: FY02/2010 Q1 Results Earnings Release Presentation

2009.04.07: FY02/2009 Q4 Results Earnings Release Presentation

2009.03.24: Modification of Earnings Forecast

2009.03.18: Notice concerning acquisition result and acquisition end of company’s own shares.

2009.02.26: Notice concerning the decision of matters relating to acquisition of company’s own shares.

2009.01.23: Co-Promotion Agreement of “FOSAMAC”